Stocks · Consumer Cyclical · Personal Products & Services
Medifast, Inc. MED
$11.73 +2.62% Close, Oct 2, 2026 · NYSE · Market cap $130.4M
High risk
Next earnings report: Nov 9, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Diluted EPS over the last four quarters was $-2.33, down 828.1% year over year.
- Revenue over the last four quarters was $316.9M, down 34.0% from a year earlier, accelerating from -36.3% a quarter earlier.
- The stock is in an uptrend: above its 200-day average for 43 trading days, with the 50-day average above the 200-day.
PromtFinance scores
Each score is a percentile within the Consumer Cyclical sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 2%
- EPS growth (TTM, YoY)Bottom 1%
- Revenue growth, 3-year CAGRBottom 1%
- Revenue growth accelerationTop 20%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 11%
- Gross marginTop 6%
- Operating marginBottom 9%
- Accruals (lower is better)Top 10%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 11%
- Free-cash-flow yieldBottom 32%
- EBITDA / enterprise valueBottom 9%
- Sales / enterprise valueTop 3%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 44%
- 6-month returnTop 32%
- 1-year return vs S&P 500Bottom 41%
- Distance from 52-week highTop 28%
- Trend checklist (0–4)Top 20%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 5%
- Consecutive EPS beatsTop 38%
- Share of analysts rating BuyBottom 22%
- Upside to consensus price targetTop 1%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 12%
- Maximum drawdown, 3 yearsBottom 7%
- Beta vs S&P 500 (lower is better)Bottom 34%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -36.3% | -34.0% | ↑ |
| Gross margin | 73.8% | 69.2% | ↓ |
| Operating margin | 0.1% | -5.5% | ↓ |
| FCF margin | -0.5% | 1.3% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -34.0% | -36.3% | ↑ | Bottom 2% |
| EPS growth (TTM, YoY) | -828.1% | — | Bottom 1% | |
| Gross margin | 69.2% | 73.8% | ↓ | Top 6% |
| Operating margin | -5.5% | 0.1% | ↓ | Bottom 9% |
| Net margin | -8.1% | 0.8% | ↓ | — |
| Free-cash-flow margin | 1.3% | -0.5% | ↑ | — |
| Return on invested capital | -7.7% | — | Bottom 11% | |
| Revenue growth, 3-year CAGR | -37.7% | — | Bottom 1% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -13.2%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 2.1%
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.13%
- Net buyback yield (TTM)
- 0.62%
- Shareholder yield
- 0.75%
- Share count change, 1 year
- +0.7%
- Share count change, 3-year CAGR
- +0.7%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 3, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 3
- Beats in the last 8 reports
- 7 of 8
- Average EPS surprise, last 4
- -100.0%
- Average 2-day reaction, last 8
- -0.4%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $59.67
- Target vs current price
- +408.7%
- Analysts with a rating
- 12
- Share rating Buy or Strong Buy
- 33%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 3, 2026 | +56.9% | -0.9% | +28.4% | +23.9% | — |
| May 4, 2026 | +65.5% | -2.6% | +15.4% | +16.4% | -11.6% |
| Feb 17, 2026 | +27.6% | +0.3% | -1.6% | -6.7% | +16.7% |
| Nov 3, 2025 | -2000.0% | -1.2% | -0.7% | -10.6% | -7.2% |
| Aug 4, 2025 | +221.1% | -1.7% | -6.5% | +2.0% | -7.5% |
| Apr 28, 2025 | +56.0% | +1.9% | +7.4% | +8.7% | +23.3% |
| Feb 18, 2025 | +162.5% | -0.5% | -8.9% | -11.5% | -21.5% |
| Nov 4, 2024 | +333.3% | +1.2% | +3.1% | +6.8% | -15.5% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 3, 2026 | -$0.28 | -$0.65 | +56.9% | $76.4M |
| May 4, 2026 | -$0.19 | -$0.55 | +65.5% | $76.0M |
| Feb 17, 2026 | -$0.55 | -$0.76 | +27.6% | $75.1M |
| Nov 3, 2025 | -$0.21 | -$0.01 | -2000.0% | $89.4M |
| Aug 4, 2025 | $0.23 | -$0.19 | +221.1% | $105.6M |
| Apr 28, 2025 | -$0.11 | -$0.25 | +56.0% | $115.7M |
| Feb 18, 2025 | $0.10 | -$0.16 | +162.5% | $119.0M |
| Nov 4, 2024 | $0.35 | -$0.15 | +333.3% | $140.2M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 0.27× | — | — | Top 3% |
| Free-cash-flow yield | 3.08% | — | — | Bottom 32% |
| Earnings yield | -19.86% | — | — | Bottom 11% |
P/E over the past five years
Range 5.4× – 89.6× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- -13.6%
- Earnings per share growth (TTM)
- -828.1%
- Change in P/E multiple
- +631.7%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 1
- Days above the 200-day average
- 43
- 50-day average slope (20 days)
- +5.0%
- 200-day average slope (20 days)
- +0.7%
- Distance from 50-day average
- +0.4%
- Distance from 200-day average
- +4.2%
- RSI (14)
- 47.6
- Relative volume
- 0.72×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 71.3%
- Volatility vs own 5-year history
- 93th percentile · High for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.21
- Correlation with S&P 500
- 0.41
- Current drawdown from 1-year high
- -16.4%
- Maximum drawdown, 3 years
- -87.6%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| May 28, 2021 | Jul 23, 2026 | -97.2% | 1292 days | Not yet recovered |
| Feb 12, 2021 | Mar 29, 2021 | -24.4% | 30 days | 28 days (May 7, 2021) |
| Sep 28, 2020 | Oct 30, 2020 | -15.1% | 24 days | 4 days (Nov 5, 2020) |
| Dec 1, 2020 | Dec 11, 2020 | -10.7% | 8 days | 16 days (Jan 6, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $130.4M
- EPS, diluted (TTM)
- -$2.33
- Revenue (TTM)
- $316.9M
- 52-week range
- $9.22 – $14.15
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $1.53B | $1.60B | $1.07B | $602.5M | $385.8M |
| Gross profit | $1.13B | $1.14B | $775.9M | $444.6M | $275.2M |
| Operating income | $216.2M | $184.8M | $126.4M | $2.9M | -$14.2M |
| Net income | $164.0M | $143.6M | $99.4M | $2.1M | -$18.7M |
| EPS (diluted) | $13.89 | $12.73 | $9.10 | $0.19 | -$1.70 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $140.2M | $119.0M | $115.7M | $105.6M | $89.4M | $75.1M | $76.0M | $76.4M |
| Net income | $1.1M | $801,000 | -$772,000 | $2.5M | -$2.3M | -$18.1M | -$2.1M | -$3.1M |
| EPS (diluted) | $0.10 | $0.07 | -$0.07 | $0.22 | -$0.21 | -$1.65 | -$0.19 | -$0.28 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $94.5M | $194.6M | $147.7M | $24.5M | $6.9M |
| Capital expenditure | -$34.2M | -$16.7M | -$6.5M | -$7.5M | -$5.6M |
| Free cash flow | $60.3M | $177.9M | $141.2M | $17.0M | $1.2M |
| Dividends paid | -$63.9M | -$71.6M | -$73.0M | -$715,000 | -$195,000 |
| Net share buybacks | -$61.3M | -$128.0M | -$7.0M | -$836,000 | -$369,000 |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $169.8M
- Total assets
- $260.4M
- Total liabilities
- $64.0M
- Total debt
- $27.6M
- Net debt
- -$44.3M
- Shareholders’ equity
- $196.4M
As of Jun 30, 2026 (filed Aug 3, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Sep 18, 2023 | $1.65 | Nov 7, 2023 |
| Jun 26, 2023 | $1.65 | Aug 8, 2023 |
| Mar 27, 2023 | $1.65 | May 9, 2023 |
| Dec 19, 2022 | $1.64 | Feb 7, 2023 |
| Sep 19, 2022 | $1.64 | Nov 8, 2022 |
| Jun 27, 2022 | $1.64 | Aug 8, 2022 |
| Mar 28, 2022 | $1.64 | May 9, 2022 |
| Dec 20, 2021 | $1.42 | Feb 8, 2022 |
Short interest
- Shares sold short
- 1,862,070
- Days to cover
- 20.02
- Change vs previous report
- -1.1%
FINRA short interest, settlement date Sep 15, 2026.